ELEM Biotech’s CEO, Christopher Morton, explained to El Periódico how the company develops digital replicas of human organs, including the heart. These digital twins allow simulation of patient-specific therapies, testing of drug effects, and collaboration with hospitals and pharmaceutical companies, leveraging supercomputing at the Barcelona Supercomputing Center to advance precision medicine.
